| Description: |
A new study explains why some melanoma tumors are resistant to BRAF inhibitor treatment. Melanoma is the deadliest form of skin cancer, killing more than 8,000 people in the U.S. each year. Approximately 50 percent of melanoma tumors are driven by mutations in the BRAF gene, and patients with these tumors are prescribed BRAF inhibitors. [Source: ScienceDaily]
|
 |
